Gamida Cell Ltd. Announces Resignation of Tracey Lodie as Chief Scientific Officer, Effective on July 9, 2021
June 26, 2021 at 01:46 am IST
On June 25, 2021, Gamida Cell Ltd. announced that Dr. Tracey Lodie, the company’s chief scientific officer, has tendered her resignation, effective on July 9, 2021, to pursue another opportunity at a private cell therapy company outside the area of oncology. Dr. Lodie will remain engaged with Gamida Cell by serving as a scientific advisor and consultant to the company to see both omidubicel and GDA-201 through key regulatory and development milestones.